skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Urinary chromium concentrations in humans following ingestion of safe doses of hexavalent and trivalent chromium: Implications for biomonitoring

Journal Article · · Journal of Toxicology and Environmental Health
OSTI ID:482323
; ;  [1]
  1. McLaren/Hart Environmental Engineering Corp., Cleveland, OH (United States); and others

This study evaluates the significance of increased urinary chromium concentrations as a marker of chromium exposure and potential health risk. Six human volunteers ingested trivalent chromium [Cr(III)] and hexavalent chromium [Cr(VI)] at doses that are known to be safe but higher than typical levels. The following dosing regimen was used: d 1-7, 200 {mu}g/d chromium picolinate; d 8-10, Cr(VI) ingestion at the U.S. Environmental Protection Agency (EPA) reference dose (RfD) of 0.005 mg/kg/d; d 11-13, no dose; d 14-16, Cr(III) ingestion at the U.S. EPA RfD of 1.0 mg/kg/d; and 17-18, postdose. Findings are as follows: (1) ingestion of 200 {mu}g/d of chromium picolinate yielded significantly elevated urine concentrations such that each participant routinely exceeded background, (2) ingestion of the Cr(VI) RfD (0.005 mg/kg/d) yielded individual mean urinary chromium levels (1.2-2.3 {mu}g/L) and a pooled mean urinary chromium level (2.4 {mu}g/L) that significantly exceeded background, and (3) ingestion of the Cr(III) RfD yielded no significantly exceeded background, and (3) ingestion of the Cr(III) RfD yielded no significant increase in urinary chromium concentrations, indicating that little, if any, absorption occurred. Our work identified three critical issues that need to be accounted for in any future studies that will use urinary chromium as a marker of exposure. First, a minimum urinary chromium concentration of approximately 2 {mu}g/L should be used as a screening level to critically identify individuals who may have experienced elevated exposures to chromium. Second, if Cr(III) levels in soils are known to be less than 80,000 ppm and the Cr(III) is insoluble, urinary chromium concentrations are not an appropriate marker of exposure. Third, newer forms of chromium supplements that contain organic forms of Cr(III) must be considered potential confounders and their contribution to residential chromium uptake must be carefully evaluated. 19 refs., 7 figs., 3 tabs.

OSTI ID:
482323
Journal Information:
Journal of Toxicology and Environmental Health, Vol. 48, Issue 5; Other Information: PBD: 9 Aug 1996
Country of Publication:
United States
Language:
English

Similar Records

Assessment of the human health risks posed by exposure to chromium-contaminated soils
Journal Article · Fri Feb 01 00:00:00 EST 1991 · Journal of Toxicology and Environmental Health; (USA) · OSTI ID:482323

Ingestion of chromium(VI) in drinking water by human volunteers: Absorption, distribution, and excretion of single and repeated doses
Journal Article · Wed Jan 01 00:00:00 EST 1997 · Journal of Toxicology and Environmental Health · OSTI ID:482323

Observation of steady state in blood and urine following human ingestion of hexavalent chromium in drinking water
Journal Article · Fri Dec 06 00:00:00 EST 1996 · Journal of Toxicology and Environmental Health · OSTI ID:482323